TrialPanorama/TrialPanorama-database huggingface dataset:
Study 36059420 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32129791 — Surrogate Endpoint (SUR): Blood pressure
Study 34558966 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34558966 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35066737 — Surrogate Endpoint (SUR): Blood pressure
Study 32503608 — Monitoring Biomarker (MOI): HBV DNA
Study 32503608 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 32503608 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32441353 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 32441353 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32019557 — Surrogate Endpoint (SUR): Blood pressure
Study 35750637 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35618953 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 35618953 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study 33621540 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32058020 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 35352280 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 34140229 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35722165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36039949 — Surrogate Endpoint (SUR): Complete renal response
Study 33221932 — Surrogate Endpoint (SUR): Blood pressure
Study 32152513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32152513 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32152513 — Surrogate Endpoint (SUR): Blood pressure
Study 33726499 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 36069821 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36069821 — Predictive Biomarker (PRD): Hormone receptor
Study 32740950 — Surrogate Endpoint (SUR): Bacterial count
Study 32843081 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32843081 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 32525525 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 36183105 — Surrogate Endpoint (SUR): Serum sodium
Study 32980866 — Surrogate Endpoint (SUR): Blood pressure
Study 33726804 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 32898517 — Surrogate Endpoint (SUR): Blood pressure
Study 33714975 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study 32122822 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 35504836 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35504836 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 36256505 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 35962638 — Surrogate Endpoint (SUR): Blood pressure
Study 32723508 — Predictive Biomarker (PRD): miR-145
Genes: MIR145
Study 32723508 — Monitoring Biomarker (MOI): miR-29a
Genes: MIR29A
Study 32723508 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-150
Genes: MIR150
Study 32668588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 33511686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35522238 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33246497 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study 35232509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35232509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35232509 — Surrogate Endpoint (SUR): Blood pressure
Study 616063448 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34656876 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33325010 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32394880 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33671260 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 33026895 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 34979180 — Surrogate Endpoint (SUR): Blood pressure
Study 32967726 — Surrogate Endpoint (SUR): Serum creatinine
Study 33748529 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34582775 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36126144 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study 36126144 — Predictive Biomarker (PRD): PSG2 mRNA
Genes: PSG2; PSBG2
Study 36126144 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 36126144 — Predictive Biomarker (PRD): PLTP mRNA
Genes: PLTP
Study 36126144 — Predictive Biomarker (PRD): IGF2R mRNA
Genes: IGF2R; MPRI
Study 33290307 — Predictive Biomarker (PRD): SVOP mRNA
Genes: SVOP
Study 35977025 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35977025 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32162943 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32926462 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 32926462 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 33872417 — Surrogate Endpoint (SUR): Blood pressure
Study 33478383 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study 32543162 — Surrogate Endpoint (SUR): Blood pressure
Study 33597131 — Surrogate Endpoint (SUR): Blood pressure
Study 35760691 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33823786 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 34862870 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 34862870 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34862870 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36005503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36005503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36005503 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35199421 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 35199421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 36115888 — Surrogate Endpoint (SUR): Bone mineral density
Study 32356115 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34197772 — Surrogate Endpoint (SUR): Bone mineral density
Study 34376488 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34376488 — Surrogate Endpoint (SUR): Serum calcium
Study 35657320 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33852330 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35210132 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35210132 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33835414 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34054104 — Predictive Biomarker (PRD): PGR mRNA
Genes: PGR; NR3C3
Study 35641166 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 35037125 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 34283660 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 34517195 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36027380 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36027380 — Surrogate Endpoint (SUR): Blood pressure
Study 36027380 — Surrogate Endpoint (SUR): Serum creatinine
Study 35720885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35659064 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35320892 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 35320892 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32752077 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 35444271 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33762240 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35100025 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 35100025 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 33420114 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32368869 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 36173596 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36173596 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35793700 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32275028 — Surrogate Endpoint (SUR): Blood pressure
Study 34511585 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 34511585 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34454995 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 32573058 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 32795561 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32795561 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32674098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32674098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32674098 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 34559946 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 34559946 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study 34559946 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33721561 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33721561 — Predictive Biomarker (PRD): Hormone receptor
Study 32801696 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 33858378 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 34670665 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34881557 — Surrogate Endpoint (SUR): Blood pressure
Study 33563147 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32862232 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32862232 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34238381 — Predictive Biomarker (PRD): SLC45A2 mRNA
Genes: SLC45A2; AIM1; MATP
Study 34238381 — Predictive Biomarker (PRD): TYR mRNA
Genes: TYR
Study 34048275 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 32390703 — Predictive Biomarker (PRD): STK11 mRNA
Genes: STK11; LKB1; PJS
Study 32390703 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 32390703 — Predictive Biomarker (PRD): AXIN2 mRNA
Genes: AXIN2
Study 32390703 — Predictive Biomarker (PRD): BMPR1A mRNA
Genes: BMPR1A; ACVRLK3; ALK3
Study 32390703 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study 32390703 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 32390703 — Predictive Biomarker (PRD): MLH3 mRNA
Genes: MLH3
Study 32390703 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 32390703 — Predictive Biomarker (PRD): MUTYH mRNA
Genes: MUTYH; MYH
Study 32390703 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 32390703 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study 36498393 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 36498393 — Safety Biomarker (SAF): Interleukin 1
Study 33318523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33318523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34352792 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 33039952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33470039 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33470039 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 33164984 — Predictive Biomarker (PRD): TCF3 mRNA
Genes: TCF3; BHLHB21; E2A; ITF1
Study 33164984 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 33164984 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 33164984 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 33164984 — Predictive Biomarker (PRD): SLC19A1 mRNA
Genes: SLC19A1; FLOT1; RFC1
Study 33164984 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 33164984 — Predictive Biomarker (PRD): ABCC4 mRNA
Genes: ABCC4; MOATB; MRP4
Study 34052278 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36166026 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33812497 — Predictive Biomarker (PRD): Microsatellite instability
Study 36163868 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34487977 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study 33119613 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 32242399 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 36310098 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35029706 — Surrogate Endpoint (SUR): Blood pressure
Study 34239138 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32051304 — Surrogate Endpoint (SUR): Blood pressure
Study 35964210 — Predictive Biomarker (PRD): CARD16 mRNA
Genes: CARD16; COP; COP1
Study 36306478 — Surrogate Endpoint (SUR): Blood pressure
Study 34582369 — Surrogate Endpoint (SUR): Serum creatinine
Study 34582369 — Surrogate Endpoint (SUR): Blood pressure
Study 35007127 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 35128870 — Surrogate Endpoint (SUR): Serum creatinine
Study 35339652 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32665039 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 33919991 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 33919991 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 33919991 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33378391 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 616115985 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 616115985 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 36031355 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33494132 — Predictive Biomarker (PRD): FADS2 mRNA
Genes: FADS2
Study 33431491 — Safety Biomarker (SAF): Reactive oxygen species
Study 32998143 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32998143 — Surrogate Endpoint (SUR): Blood pressure
Study 32998143 — Surrogate Endpoint (SUR): Serum creatinine
Study 32998143 — Surrogate Endpoint (SUR): Serum potassium
Study 32015491 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32015491 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study 34516535 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32217654 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35840306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35840306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32331584 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36322844 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 34785108 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34785108 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35171682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35171682 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 35171682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35220312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35220312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34887261 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34887261 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35080055 — Surrogate Endpoint (SUR): Blood pressure
Study 33957506 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 33098211 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32920808 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35281950 — Monitoring Biomarker (MOI): Procalcitonin
Study 35281950 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35281950 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33159526 — Surrogate Endpoint (SUR): Blood pressure
Study 35840157 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32919110 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 35684118 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35684118 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34477469 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 34236435 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study 32809261 — Surrogate Endpoint (SUR): Serum potassium
Study 32302705 — Surrogate Endpoint (SUR): Probing pocket depth
Study 34254834 — Surrogate Endpoint (SUR): Urinary oxalate
Study 33319444 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 33149896 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 32161944 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34260860 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 35476316 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 32534584 — Surrogate Endpoint (SUR): Blood pressure
Study 32216218 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 34255080 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 32371539 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33219482 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33219482 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32400738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35672894 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35672894 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35672894 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33207743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35443373 — Surrogate Endpoint (SUR): Blood pressure
Study 32582177 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32582177 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 34115064 — Safety Biomarker (SAF): Reactive oxygen species
Study 35209731 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35209731 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34607285 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32185840 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36509889 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33306564 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32253548 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32253548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32253548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32498372 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 34928484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1